Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1095084.RAa4xnxPt0-4B8gbMD0SgO-qLc6dhCFLXr8BT2NLNwgbM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1095084.RAa4xnxPt0-4B8gbMD0SgO-qLc6dhCFLXr8BT2NLNwgbM130_assertion type Assertion NP1095084.RAa4xnxPt0-4B8gbMD0SgO-qLc6dhCFLXr8BT2NLNwgbM130_head.
- NP1095084.RAa4xnxPt0-4B8gbMD0SgO-qLc6dhCFLXr8BT2NLNwgbM130_assertion description "[We evaluated Ad.5/3-CTV in comparison with Ad.5-CTV in low CAR human PC cells, demonstrating higher efficiency in inhibiting cell viability in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1095084.RAa4xnxPt0-4B8gbMD0SgO-qLc6dhCFLXr8BT2NLNwgbM130_provenance.
- NP1095084.RAa4xnxPt0-4B8gbMD0SgO-qLc6dhCFLXr8BT2NLNwgbM130_assertion evidence source_evidence_literature NP1095084.RAa4xnxPt0-4B8gbMD0SgO-qLc6dhCFLXr8BT2NLNwgbM130_provenance.
- NP1095084.RAa4xnxPt0-4B8gbMD0SgO-qLc6dhCFLXr8BT2NLNwgbM130_assertion SIO_000772 23868767 NP1095084.RAa4xnxPt0-4B8gbMD0SgO-qLc6dhCFLXr8BT2NLNwgbM130_provenance.
- NP1095084.RAa4xnxPt0-4B8gbMD0SgO-qLc6dhCFLXr8BT2NLNwgbM130_assertion wasDerivedFrom befree-2016 NP1095084.RAa4xnxPt0-4B8gbMD0SgO-qLc6dhCFLXr8BT2NLNwgbM130_provenance.
- NP1095084.RAa4xnxPt0-4B8gbMD0SgO-qLc6dhCFLXr8BT2NLNwgbM130_assertion wasGeneratedBy ECO_0000203 NP1095084.RAa4xnxPt0-4B8gbMD0SgO-qLc6dhCFLXr8BT2NLNwgbM130_provenance.